Market intelligence for competitive advantage to the world's leading and emerging medtech companies.

Reports | Consult | Medtech Startups | Fundings

Global Market Opportunities in Peripheral Arterial and Venous Stents, Forecast to 2020

· 208 pages   · 42 Exhibits   · 15 Company Profiles   · Report #V201   · Published February 2016

Price: $3,950 (print or PDF; add $200 for both).
Site/Global License also available.

Order or send us your order form.

This report is a market analysis of products and technologies used for peripheral arterial and venous stenting. First introduced about two decades ago as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications outside the domain of coronary and cerebral vasculature.  Today, peripheral vascular stenting techniques are commonly employed in the management of the most prevalent occlusive circulatory disorders and other pathologies affecting the abdominal and thoracic aortic tree and lower extremity arterial bed. Stents are also increasingly used in the management of the debilitating conditions like venous outflow obstruction associated with deep venous thrombosis and chronic venous insufficiency.

 

The report provides full year (actual) 2014 caseload and procdure volume data, market size and share data, with forecast market data to 2020, for the U.S., Western Europe, Asia/Pacific, and Rest of World, for peripheral applications of bare metal stents, drug-eluting stents, thoracic and abdominal aortic aneurysm stents, and peripheral venous stents.

 

TABLE OF CONTENTS

Executive Summary

Section 1: Global Healthcare Market Environment

1.1 United States

1.1.1 United States

1.2 Major Western European States

1.2.1 Overview of European Healthcare

1.2.2 Healthcare Spending and Reforms

1.2.2.1 Healthcare Facilities and Manpower

1.2.2.2 Reimbursement

1.2.2.3 Impact of the European Union

1.2.3 National Healthcare Profiles

1.2.3.1 France

1.2.3.2 Germany

1.2.3.3 Italy

1.2.3.4 Spain

1.2.3.5 United Kingdom

1.3 Major Asian States

1.3.1 China

1.3.2 India

1.3.3 Japan

Section 2: Current and Emerging Peripheral Vascular stenting Tecnologies

2.1 Stenting Device Design, Architecture and Deployment Mechanisms

2.1.1 Common Peripheral Vascular Metal Stent Designs

2.1.2 Stent Deployment Mechanisms

2.2 Stenting Device Materials

2.2.1 Metal Stents

2.2.1.1 Stainless Steel

2.2.1.2 Nickel-Titanium Alloys

2.2.1.3 Cobalt Alloys

2.2.1.4 Absorbable Magnesium Alloys

2.2.2 Standard Polymeric Stent Materials

2.2.3 Biodegradable Polymeric Stent Materials

2.3 Stent Coatings

2.3.1 Stent Radiopacity Enhancement

2.3.2 Biocompatibility Enhancing Stent Coatings

2.3.3 Active Therapeutic Coating

2.3.3.1 Current and Emerging DES Technologies

2.3.3.1.1 Anti-Restenotic Drugs

2.3.3.1.2 Drug Delivery Techniques

2.3.4 Stent Coverings/Linings

Section 3: Etiology and Epidemiology of Peripheral Vascular Conditions Targeted by stenting

3.1 Functional Anatomy and Physiology of Human Vascular Circulatory System

3.2 Peripheral Vascular Conditions Targeted by Stenting

3.2.1 Peripheral Arterial Disorders

3.2.1.1 Lower Extremity Arterial Occlusions & Critical Limb Ischemia

3.2.1.1.1 Critical Limb Ischemia

3.2.1.2 Established Treatment Modalities for Symptomatic PAD and CLI

3.2.1.2.1 Lower Extremity Stenting

3.2.1.2.1.1 Iliac Artery Stenting

3.2.1.2.1.2 Femoro-Popliteal Artery Stenting

3.2.1.2.1.3 Infrapopliteal (Below-the-Knee) Stenting

3.2.1.2.1.4 Lower Extremity Arterial Stenting Procedure Volumes

3.2.2 Aortic Aneurysm

3.2.2.1 Aortic Aneurysm Treatment Regimens

3.2.2.1.1 Surgical Repair of Aortic Aneurysm

3.2.2.1.2 Abdominal Aortic Aneurysm Repair with Endovascular Stent-Grafts

3.2.2.1.2.1 Limitations of Endovascular AAA Repair

3.2.2.1.3 Endovascular Repair of TAA

3.3 Peripheral Venous Diseases

3.3.1.1 Functional Anatomy and Physiology of Venous Circulation

3.3.1.2 Deep Venous Thrombosis

3.3.1.2.1 Established Treatment Modalities

3.3.1.2.2 DVT Patient Caseloads

3.3.1.2.3 Pulmonary Embolism

3.3.1.2.3.1 Established Treatment Modalities

3.3.1.2.3.2 PE Patient Caseloads

3.3.1.3 Chronic Venous Insufficiency

3.3.1.3.1 Established Treatment Modalities

3.3.1.3.2 CVI Patient Caseloads

3.3.1.3.3 Peripheral Venous Stenting

3.3.1.3.3.1 Accumulated Clinical Experience With Venous Stenting

3.3.1.3.3.2 Venous Stenting Procedure Volumes

Section 4: Worldwide Market for Peripheral Arterial and Venous Stenting Systems

4.1 Lower Extremity Arterial Stenting Systems

4.1.1 Industry Product Offering

4.1.2 Market Forecast

4.1.2.1 Competitive Analysis

4.2 Endovascular Aortic Aneurysm Repair Systems

4.2.1 Industry Product Offering in AAA and TAA Stent-Grafts

4.2.2 Market Forecast

4.2.2.1 Competitive Analysis

4.3 Venous Stenting Systems

4.3.1 Industry Product Offering

4.3.1.1 Product Trends and Trials

4.3.1.2 Competitive Analysis

Section 5: Company Profiles

5.1 Abbott Vascular / Abbott Laboratories

5.2 Bard Peripheral Vascular / Bard C.R.

5.3 Biosensors International

5.4 Biotronik

5.5 Boston Scientific

5.6 Cardinal Health / Cordis

5.7 Cook Medical

5.8 Endologix

5.9 Gore & Associates

5.10 iVascular

5.11 Lifetech Scientific

5.12 Medtronic / Covidien

5.12.1 Covidien

5.12.2 Medtronic

5.13 Optimed

5.14 Terumo

5.15 Veniti

COMPANY LISTING

Exhibit ES-1: Projected Global and Regional Dynamics of Peripheral Arterial and Venous Stenting Procedures, 2014-2020 (#000)

Exhibit ES-2: Projected Global and Regional Dynamics of Peripheral Arterial and Venous Stenting Market, 2014-2020 ($mil)

Exhibit ES-3: Worlwide Peripheral Stent Market By Product Category, 2015 and 2020 ($mil)

Exhibit 1-1: United States, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-2: France, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-3: Germany, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-4: Italy, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-5: Spain, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-6: United Kingdom, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-7: China, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-8: India, Selected Healthcare/Public Health Indicators, 2014

Exhibit 1-9: Japan, Selected Healthcare/Public Health Indicators, 2014

Exhibit 2-1: Selected Biomedical, Clinical and Technical Requirements for Stenting Implants

Exhibit 2-2: Comparative Advantages and Drawbacks of Most Common Stenting Device Designs

Exhibit 2-3: Comparative Characteristics of Established & Emerging Metal Stent Materials

Exhibit 2-4: Selected Characteristics of Polymeric Stent Materials

Exhibit 2-5: Selected Characteristics of Anti-Restenosis Agents Employed by the Leading Developers of DES Systems

Exhibit 2-6: Perceived Advantages and Disadvantages of Non-Resorbable and Biodegradable Drug Carriers for DES Systems

Exhibit 3-1: Peripheral Atherosclerosis and Critical Limb Ischemia: Facts And Figures (2015)

Exhibit 3-2: Current and Projected Global and Regional Data on Prevalence of Symptomatic PAD and CLI, 2014-2020 (#000)

Exhibit 3-3: Projected Dynamics of the Lower Extremity Stenting Procedures 2014-2020 (#000)

Exhibit 3-4: Aortic Aneurysm: Facts And Figures (2015)

Exhibit 3-5: Estimated Incidence and Prevalence of Abdominal and Thoracic Aortic Aneurysms, 2014-2020 (#000)

Exhibit 3-5: Estimated Incidence and Prevalence of Abdominal and Thoracic Aortic Aneurysms, 2014-2020 (#000)

Exhibit 3-6: Projected Dynamics of AAA and TAA Endovascular Repair Procedures. 2014-2020 (#000)

Exhibit 3-7: Clinical Features and Characteristics of Deep Venous Thrombosis

Exhibit 3-8: Current and Projected Global and Regional Data on Incidence and Prevalence of DVT, 2014-2020 (#000)

Exhibit 3-9: Clinical Features and Characteristics of Pulmonary Embolism

Exhibit 3-10: Current and Projected Global and Regional Data on Incidence and Prevalence of PE, 2014-2020 (#000)

Exhibit 3-11: Clinical Features and Characteristics of Chronic Venous Insufficiency

Exhibit 3-12: Current and Projected Global and Regional Data on Prevalence of CVI, 2014-2020 (#000)

Exhibit 3-13: Projected Dynamics of Peripheral Venous Stenting Procedures, 2014-2020 (#000)

Exhibit 4-1: Projected Global and Regional Dynamics of Peripheral Arterial and Venous Stenting Procedures, 2014-2020 (#000)

Exhibit 4-2: Projected Global and Regional Dynamics of Peripheral Arterial and Venous Stenting Market, 2014-2020 ($mil)

Exhibit 4-3: Selected Industry Product Offering in Peripheral Arterial Stents

Exhibit 4-4: Projected Dynamics of Peripheral Arterial Stenting Device Market, 2014-2020

Exhibit 4-6: Selected Endovascular Aortic Aneurysm Repair Systems on the market

Exhibit 4-7: Projected Dynamics of AAA & TAA StentGrafting Device Market, 2014-2020

Exhibit 4-8: Estimated Market Shares of the Leading Suppliers of AAA and TAA Stent-Grafts, 2015

Exhibit 4-10: Projected Dynamics of Peripheral Venous Stenting Device Market, 2014-2020

Exhibit 4-11: Estimated 2015 Market Shares of the Leading Global Market Suppliers of Peripheral Venous Stents

 


Methodology.
MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by proven authors who are neutral industry insiders, whose familiarity with clinical practice, biomedical techcnologies, companies, and industry dynamics facilitate the research process and ensure high quality and thorough reports.


Global Market Opportunities in Peripheral Arterial and Venous Stents, Forecast to 2020

February 2016

 

Price:  $3,950 (print or PDF; add $200 for both).  Site/Global License also available. 

 

For immediate download, order online or fax your order form.  Site/Global License also available.

 


Order Reports online for instant download.
See Online Store or any "order online" link.
Credit Card Processing

Refund Policy: MedMarket Diligence print products are refundable if returned in salable condition within 30 (thirty) days of purchase date. Electronic products (PDF, online database subscription) are non-refundable; clients are urged to review content on mediligence.com or contact MedMarket Diligence directly via phone or email in advance of purchase to ensure that electronic products will meet customer needs.

Reports library access is also available through annual contract.


Medtech Startups Database

MedMarket Diligence offers the Medtech Startups Database.
A unique source of detail on new medical technology companies

About the Medtech Startups Database.